Fractyl Health, Inc. Common Stock Q3 2026 Earnings Call Summary
Canaccord Genuity Maintains Buy on Fractyl Health, Raises Price Target to $40
HC Wainwright & Co. Maintains Buy on Fractyl Health, Raises Price Target to $24
Fractyl Health (GUTS) Q3 2026 Earnings Call Transcript
Fractyl Health Inc (GUTS) Q3 2026 Earnings Call Highlights: Revita Hits Key Endpoint as ...
Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates
Fractyl Health, Inc. (GUTS) Q3 2026 Earnings Call Transcript
Fractyl Health Q3 EPS $(1.07) Beats $(1.51) Estimate
Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026
Fractyl Health (GUTS) Stock Fair Value Falls After Mixed Revita Analyst Reactions
Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization
Fractyl Health Expands Revita Patent Portfolio Ahead Of Planned FDA De Novo Submission
Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance
Fractyl Health (GUTS) Stock Sees Fair Value Cut After Mixed Revita Analyst Reactions
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance
Fractyl Health Announces Heightened Focus On Advancing Revita Toward Potential FDA Marketing Authorization And Commercialization In Post-GLP-1 Weight Maintenance
Canaccord Genuity Maintains Buy on Fractyl Health, Lowers Price Target to $39
Morgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4
Fractyl Health, Inc. (GUTS) Discusses Positive Top Line 6-Month Results From REMAIN-1 Study of Revita in Post GLP-1 Weight Maintenance Transcript
Fractyl Health Meets Six-Month Primary Endpoint in Revita Obesity Trial, Supporting FDA Submission Plans
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.